Found: 7
Select item for more details and to access through your institution.
Front Cover: Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity (ChemMedChem 1/2020).
- Published in:
- ChemMedChem, 2020, v. 15, n. 1, p. 1, doi. 10.1002/cmdc.201900683
- By:
- Publication type:
- Article
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity.
- Published in:
- ChemMedChem, 2020, v. 15, n. 1, p. 17, doi. 10.1002/cmdc.201900497
- By:
- Publication type:
- Article
Characterization of serum biomarkers for detection of early stage ovarian cancer.
- Published in:
- Proteomics, 2005, v. 5, n. 17, p. 4589, doi. 10.1002/pmic.200500093
- By:
- Publication type:
- Article
Conjugation of Indoles to Antibodies through a Novel Self‐Immolating Linker.
- Published in:
- Chemistry - A European Journal, 2018, v. 24, n. 19, p. 4830, doi. 10.1002/chem.201800859
- By:
- Publication type:
- Article
Differential Effects of Predosing on Tumor and Tissue Uptake of an <sup>111</sup>In-Labeled Anti-TENB2 Antibody–Drug Conjugate.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 9, p. 1454, doi. 10.2967/jnumed.112.103168
- By:
- Publication type:
- Article
Evaluation and use of an anti-cynomolgus monkey CD79b surrogate antibody-drug conjugate to enable clinical development of polatuzumab vedotin.
- Published in:
- 2019
- By:
- Publication type:
- journal article
An integrated approach to identify normal tissue expression of targets for antibody-drug conjugates: case study of TENB2.
- Published in:
- British Journal of Pharmacology, 2013, v. 168, n. 2, p. 445, doi. 10.1111/j.1476-5381.2012.02138.x
- By:
- Publication type:
- Article